Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection

COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome. We present a case in which antiphospholipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitterman, Lauren, Solhjoo, Mahdis, Shah, Vivek, Kwon, Sue Min, Torralba, Karina, Kazbour, Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102817/
https://www.ncbi.nlm.nih.gov/pubmed/37052044
http://dx.doi.org/10.1177/23247096231165736
_version_ 1785025767767277568
author Bitterman, Lauren
Solhjoo, Mahdis
Shah, Vivek
Kwon, Sue Min
Torralba, Karina
Kazbour, Hana
author_facet Bitterman, Lauren
Solhjoo, Mahdis
Shah, Vivek
Kwon, Sue Min
Torralba, Karina
Kazbour, Hana
author_sort Bitterman, Lauren
collection PubMed
description COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome. We present a case in which antiphospholipid antibodies were detected in the presence of significant thromboses. The patient was subsequently treated for suspected catastrophic antiphospholipid syndrome following COVID-19 infection.
format Online
Article
Text
id pubmed-10102817
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-101028172023-04-15 Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection Bitterman, Lauren Solhjoo, Mahdis Shah, Vivek Kwon, Sue Min Torralba, Karina Kazbour, Hana J Investig Med High Impact Case Rep Case Report COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome. We present a case in which antiphospholipid antibodies were detected in the presence of significant thromboses. The patient was subsequently treated for suspected catastrophic antiphospholipid syndrome following COVID-19 infection. SAGE Publications 2023-04-13 /pmc/articles/PMC10102817/ /pubmed/37052044 http://dx.doi.org/10.1177/23247096231165736 Text en © 2023 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Bitterman, Lauren
Solhjoo, Mahdis
Shah, Vivek
Kwon, Sue Min
Torralba, Karina
Kazbour, Hana
Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
title Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
title_full Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
title_fullStr Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
title_full_unstemmed Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
title_short Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
title_sort catastrophic antiphospholipid syndrome as a complication of covid-19 infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102817/
https://www.ncbi.nlm.nih.gov/pubmed/37052044
http://dx.doi.org/10.1177/23247096231165736
work_keys_str_mv AT bittermanlauren catastrophicantiphospholipidsyndromeasacomplicationofcovid19infection
AT solhjoomahdis catastrophicantiphospholipidsyndromeasacomplicationofcovid19infection
AT shahvivek catastrophicantiphospholipidsyndromeasacomplicationofcovid19infection
AT kwonsuemin catastrophicantiphospholipidsyndromeasacomplicationofcovid19infection
AT torralbakarina catastrophicantiphospholipidsyndromeasacomplicationofcovid19infection
AT kazbourhana catastrophicantiphospholipidsyndromeasacomplicationofcovid19infection

Ejemplares similares